COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,673 Articles (22,913 medRxiv, 8,760 bioRxiv)

Most recent first Previous |  Page 261: Articles 2601-2610  | Next

Multimolecular feature-based machine learning: system biology enhanced RF-QSAR modeling for the efficient prediction of the inhibitory potential of diverse SARS CoV-2 3CL Protease inhibitors
Manaithiya, A., Bhowmik, R., Ray, R., Kumar, S., Sharma, S., Mathew, B., Gong, W., Parkkila, S., Aspatwar, A.
10.1101/2024.04.30.591922 — Posted: 2024-05-03
Interferon-Inducible Guanylate-Binding Protein 5 Inhibits Replication of Multiple Viruses by Binding to the Oligosaccharyltransferase Complex and Inhibiting Glycoprotein Maturation
Wang, S., Li, W., Wang, L., Tiwari, S. K., Bray, W., Wu, L., Li, N., Hui, H., Clark, A., Zhang, Q., Zhang, L., Carlin, A., Rana, T. M.
10.1101/2024.05.01.591800 — Posted: 2024-05-03
Evidence that the SARS-CoV-2 S protein undergoes a conformational change at the Golgi Complex that leads to the formation of virus neutralising antibody binding epitopes in the S1 protein subunit.
Sugrue, R. J., Tan, B. H., Lai, S. K., Chan, C. E.-Z., Wu, Y.
10.1101/2024.05.01.591558 — Posted: 2024-05-03
Factors influencing long-term recovery in critically ill COVID-19 survivors: A prospective multicentre cohort study
Didriksson, I., Frigyesi, A., Spangfors, M., Leffler, M., Reepalu, A., Nilsson, A., Annborn, M., Lybeck, A., Friberg, H., Lilja, G.
10.1101/2024.05.01.24306267 — Posted: 2024-05-02
Long-COVID improves in 50% of patients after a year in a Midwestern cohort
Stalker, G., Tudas, R., Garg, A., Graham, L., Thurman, A., Wiblin, R. T., Hamzeh, N., Blount, R., Villacreses, R., Zabner, J., Comellas, A., Cho, J., Pezzulo, A.
10.1101/2024.04.30.24306497 — Posted: 2024-05-01
The tryptophan catabolite or kynurenine pathway in Long COVID disease: A systematic review and meta-analysis
Almulla, A. F., Thipakorn, Y., Zhou, B., Vojdani, A., Paunova, R., Maes, M.
10.1101/2024.04.30.24306635 — Posted: 2024-05-01
A Tip Optofluidic Immunoassay System for COVID-19 Immuno-protection Evaluation Using Fingertip Blood
Li, R., Zhang, B., Li, H., An, L., Zhu, T., Hu, S., Yang, F., Wu, W., Fan, X., Chai, Y., Yang, H., Tan, X.
10.1101/2024.04.29.24306554 — Posted: 2024-05-01
Temporal trajectories of COVID-19 symptoms in adults with 22 months follow-up in a prospective cohort study in Norway.
Ellingjord-Dale, M., Nygaard, A., Stoer, N., Boe, R., Landroe, N. I., Brunvoll, S. H., Istre, M., Kalleberg, K. T., Dahl, J. A., Geng, L., Tsilidis, K., Riboli, E., Ursin, G., Soeraas, A.
10.1101/2024.04.30.24306604 — Posted: 2024-05-01
Distress and factors for maintaining good mental health among general practitioners during the SARS-CoV-2 pandemic. Results from the cross-sectional PRICOV-19 study in Austria.
Hoffmann, K., Stummer, F. O., Van Poel, E., Willems, S., Wojczewski, S.
10.1101/2024.04.30.24306629 — Posted: 2024-05-01
Altered Brain Glucose Metabolism in COVID-19 disease: An activation likelihood estimation Meta-analysis
kang, D., Jung, H., Pak, K.
10.1101/2024.04.30.24306508 — Posted: 2024-05-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).